FDA To Unveil Policy Roadmap, Update Pre-Clinical Science Policies

FDA plans to unveil a new Strategic Policy Roadmap outlining the agency's policy priorities, one of which will be rolling out new pre-clinical science policies aimed at streamlining the investigational new drug and biologics license application filing processes, Commissioner Scott Gottlieb told a diverse group of patient advocates, members of the drug and device industry, medical experts and other stakeholders during Research!America's 2017 National Health Research Forum on Thursday (Sept. 7). Gottlieb said the roadmap "will serve as an organizing...